After selling 532 shares, director Daniel G. Kaye holds 4,313 directly in CME Group (CME).
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
CME Group director Daniel G. Kaye sold 532 shares of Class A common stock on November 9, 2026, for $304.17 per share. Following this transaction, Kaye directly holds 4,313 shares of CME Group. The sale was an open market or private transaction, and the Rule 10b5-1 checkbox was unchecked.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.